SCHEMBL8989151

SCHEMBL8989151

Cc1c(C=O)cc(-c2ccccc2)n1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 6/20 0.44
HPGD P15428 1/20 0.44
CCNB2 O95067 1/20 0.40
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
TSHR P16473 1/20 0.39
LMNA P02545 1/20 0.39
PTGS2 P35354 2/20 0.39
BRD4 O60885 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CYP19A1 P11511 1/20 0.38
PTGS1 P23219 1/20 0.37
MAPT P10636 1/20 0.37
NFKB1 P19838 1/20 0.37
CASP3 P42574 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7329614 0.75 KMT2A (0.44) KMT2AALDH1A1HPGDCCNB2CDK1
SCHEMBL28630613 0.75 KMT2A (0.52) KMT2AALDH1A1HPGDCCNB2CDK1
SCHEMBL1156785 0.74 ALDH1A1 (0.43) ALDH1A1HPGDLMNAPTGS2BRD4
SCHEMBL2214810 0.71 NOTUM (0.50) KMT2AALDH1A1HPGDTSHRSMN1; SMN2
SCHEMBL2518213 0.70 ALDH1A1 (0.57) KMT2AALDH1A1LMNANPC1RAB9A
SCHEMBL1156583 0.70 PTGS2 (0.55) LMNAPTGS2PTGS1MAPTSMN1; SMN2
SCHEMBL25062167 0.69 KMT2A (0.46) KMT2AALDH1A1HPGDCCNB2CDK1
SCHEMBL25062987 0.69 KMT2A (0.46) KMT2AALDH1A1HPGDCCNB2CDK1
SCHEMBL3260887 0.69 BRD4 (0.47) KMT2AALDH1A1HPGDTSHRLMNA
SCHEMBL11436206 0.69 ALDH1A1 (0.56) KMT2AALDH1A1HPGDCCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 US disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 US disclosed